Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide

Infection and Immunity

Volumn 67, Issue 8, 1999, Pages 4231-4236

  Chiang, Cheng Yang ^a   Kyritsis, George ^a   Graves, Dana T ^a   Amar, Salomon ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; BACTERIUM LIPOPOLYSACCHARIDE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA CONVERTING ENZYME; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALVARIA; CONTROLLED STUDY; GENE DELETION; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL;

EID: 0032765131     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.8.4231-4236.1999     Document Type: Article

References (46)

1. Abu-Amer, Y., F. P. Ross, J. Edwards, and S. L. Teitelbanm. 1997. LPS-stimulated osteoclastogenesis is mediated by TNF via its p55 receptor. J. Clin. Investig. 100:1557-1565.
2. Agarwal, S., N. P. Piesco, L. P. Johns, and A. E. Riccelli. 1995. Differential expression of IL-1 beta, TNF- alpha, IL-6 and IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J. Dent. Res. 74: 1057-1065.
3. Amar, S., T. E. Van Dyke, H. P. Eugster, N. Schnitze, P. Koebel, and H. Bluethmann. 1996. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1. J. Inflamm. 47:180-189.
4. Assuma, R., T. Dates, D. Cochran, S. Amar, and D. T. Graves. 1998. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J. Immunol. 16:403-409.
5. Aznar, C., C. Fitting, and J. M. Cavaillon. 1990. LPS-induced production of cytokines by bone marrow-derived macrophages: destruction between intracellular IL-1 production and IL-1 release. Cytokine 2:259-265.
6. Birkedal-Hansen, H. 1993. Role of cytokines and inflammatory mediators in tissue destruction. J. Periodontal Res. 28:500-510.
7. Bom-van Noorloos, A. A., J. W. van der Meer, J. S. van de Gevel, E. Schepens, T. J. van Steenbergen, and E. H. Burger. 1990. Bacteroides gingivalis stimulates bone resorption via interleukin-1 production by mononuclear cells. The relative role for B. gingivalis endotoxin. J. Clin. Periodontol. 17:409-413.
8. Boyce, B. F., T. B. Aufdemorte, I. R. Garrett, A. J. Yates, and G. R. Mundy. 1989. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142-1150.
9. Dinarrello, C. A., J. G. Cannon, J. W. Mier, H. A. Bernheim, G. LoPreste, D. L. Lynn, R. N. Love, A. C. Webb, P. E. Auron, R. C. Reuben, et al. 1986. Multiple biological activities of human recombinant IL-1. J. Clin. Investig. 77:1734-1739.
10. Galanos, C., and M. A. Freudenberg. 1993. Mechanism of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187:346-356.
11. Girasole, G., G. Passen, R. L. Jilka, and S. C. Manolagas. 1994. Interleukin-11: a new cytokine critical for osteoclast development. J. Clin. Investig. 93:1516-1524.
12. Glaccum, M. B., K. L. Stocking, K. Charrier, J. L. Smith, C. R. Willis, C. Maliszewski, D. J. Livingston, J. J. Peschon, and P. J. Morrissey. 1997. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunology 159:3364-3371.
13. Gowen, M., and M. C. Meikle. 1983. Stimulation of bone resorption in vitro by a non-prostanoid factor released by human monocytes in culture. Biochim. Biophys. Acta 762:471-474.
14. Graves, D. T., A. Delima, R. Assuma, S. Amar, T. Oates, and D. Cochran. 1998. IL-1 and TNF antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J. Periodontol. 69:1419-1424.
15. Hanazawa, S., S. Amano, K. Nakada, Y. Ohmori, T. Miyoshi, K. Hirose, and S. Kitano. 1987. Biological characterization of interleukin-1-like cytokine produced by cultured bone cells from newborn mouse calvaria. Calcified Tissue Int. 41:31-37.
16. Hausmann, E., B. C. Nair, and R. Dziak. 1982. Bacterial components which result in bone loss, p. 151-159. In R. J. Genco and S. E. Mergenhagen (ed.), Host-parasite interactions in periodontal diseases. American Society for Microbiology, Washington, D.C.
17. Hausmann, E., and N. Weinfeld. 1973. Human dental plaque: stimulation of bone resorption in tissue culture. Arch. Oral Biol. 18:1509-1515.
18. Ishimi, Y., C. Miyaura, C. H. Jin, T. Akatsu, E. Abe, Y. Nakamura, A. Yamaguchi, S. Yoshiki, T. Matsuda, T. Hirano, et al. 1990. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 145:3297-3303.
19. Johnson, R. A., B. F. Boyce, G. R. Mundy, and G. D. Roodman. 1989. Tumors producing human TNF induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 124:1424-1427.
20. Kimble, R. B., A. B. Matayoshi, J. L. Vannice, V. T. Rung, C. Williams, and R. Pacifici. 1995. Simultaneous block of IL-1 and TNF is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136:3054-3061.
21. Koide, M., S. Suda, S. Saitoh, Y. Ofuji, T. Suzuki, H. Yoshie, M. Takai, Y. Ono, Y. Taniguchi, and K. Hara. 1995. In vivo administration of IL-1 beta accelerates silk ligature-induced alveolar bone resorption in rats. J. Oral Pathol. Med. 24:420-434.
22. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskin, L. Rodman, J. Salfeld, et al. 1995. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80:401-411.
23. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Ann. Rev. Med. 38:417-432.
24. Orcel, P., and M. Feuga. 1993. Local bone injection of LPS and M-CSF resorption by different pathways in vivo in rats. Am. J. Physiol. 264:E391-E397.
25. Parfitt, A. M., M. K. Drezner, F. H. Glorieux, J. A. Kanis, H. Malluche, P. J. Meunier, S. M. Ott, and R. R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols and units. J. Bone Min. Res. 6:595-610.
26. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943-952.
27. Pfeilschifter, J., C. Chenu, A. Bird, G. R. Mundy, and G. D. Roodman. 1989. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J. Bone Min. Res. 4:113-118.
28. Pinckard, J. K., C. F. Kathleen, C. D. Sheehan, C. D. Arthur, and R. D. Schreiber. 1997. Constitutive shedding of both p55 and p75 murine TNF receptors in vivo. J. Immunol. 158:3869-3873.
29. Roodman, G. D. 1996. Advances in bone biology: the osteoclast. Endocrine Rev. 17:308-332.
30. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Kobel, F. Kontgen, A. Althage, R. Zinkernagel, K. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
31. Ruby, J., H. Bluethmann, J. J. Peschon. 1997. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J. Exp. Med. 186:1591-1596.
32. Sabatini, M., B. Boyce, T. Aufdemorte, L. Bonewald, and G. R. Mundy. 1988. Infusions of recombinant human IL-1 α and β cause hypercalcemia in normal mice. Proc. Natl. Acad. Sci. USA 85:5235-5239.
33. Saglie, F. R., K. Simon, J. Merrill, H. P. Koeffler. 1990. LPS from Actinobacillus actinomycetemcomitan stimulates macrophages to produce IL-1 and TNF mRNA and protein. Oral Microbiol. Immunol. 5:256-262.
34. Schwartz, J., F. L. Stinson, R. B. Parker. 1972. The passage of tritiated bacterial endotoxin across intact gingival crevicular epithelium. J. Periodontol. 43:270-276.
35. Shapira, L., S. Takashiba, S. Amar, and T. E. Van Dyke. 1994. Porphyromonas gingivalis lipopolysaccharide stimulation of human monocytes: dependence on serum and CD14 receptor. Oral Microbiol. Immunol. 9:112-117.
36. Sims, J. E., M. A. Gayle, J. L. Slack, M. R. Alderson, T. A. Bird, J. G. Giri, F. Colotta, F. Re, A. Manotvani, K. Shanebeck, K. H. Grabstein, and S. K. Dower. 1993. IL-1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90:6155-6159.
37. Sismey-Durrant, H. J., and R. M. Hopps. 1987. The effect of lipopolysaccharide from the oral bacterium Bacteroides gingivalis on osteoclastic resorption of sperm-whale dentine slices in vitro. Arch. Oral Biol. 32:911-913.
38. Suda, T., N. Takahashi, and T. J. Martin. 1992. Modulation of osteoclast differentiation. Endocrine Rev. 13:66-80.
39. Takada, H., J. Mihara, I. Morisaki, and S. Hamada. 1991. Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Infect. Immun. 59:295-301.
40. Takashi, T., M. Miyanchi, I. Ogawa, H. Ito, J. Kobayashi, and H. Nikai. 1997. Reactive change in proliferative activity of junctional epithelium after topical application of LPS. J. Periodontol. 68:531-535.
41. Thomson, S. M., G. R. Mundy, and T. J. Chambers. 1987. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J. Immunol. 138:775-779.
42. Umezu, A., N. Kaneko, Y. Toyama, and Y. Watanabe. 1989. Appearance of osteoclasts by injections of LPS in rat periodontal tissue. J. Periodontal Res. 24:378-383.
43. Uy, H. L., M. Dallas, J. W. Calland, B. F. Boyce, G. R. Mundy, and G. D. Roodman. 1995. Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. J. Bone Min. Res. 10:295-301.
44. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure, p. 157-162. In R. L. Whistler (ed.), Methods in carbohydrate chemistry, 5th ed. Academic Press Inc., New York, N.Y.
45. Williams, R. C. 1990. Periodontal disease. N. Engl. J. Med. 322:373-382.
46. Zubery, Y., C. R. Dunstan, B. M. Story, L. Kesavalu, J. L. Ebersole, S. C. Holt, and B. F. Boyce. 1999. Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin. Infect. Immun. 66:4158-4162.